Gustatory and interoceptive regulation of hypertension
高血压的味觉和内感受调节
基本信息
- 批准号:10388488
- 负责人:
- 金额:$ 3.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The overconsumption of sodium (Na+) is a major health problem in the U.S. and around the world,
having been linked to many health conditions, including hypertension—a major risk factor for
cardiovascular disease. While the relationship between Na+-intake and hypertension is widely
recognized, the mechanism(s) behind this relationship are not well understood. The proposed
experiments aim to delineate the mechanism(s) underlying this relationship by investigating
sensory systems that regulate Na+-taste/intake and blood pressure (BP). My preliminary studies
conducted in mice discovered that neurons within the nodose and petrosal ganglion that express the
angiotensin type 1a receptor (NPGAT1aR) send afferents to the nucleus of the solitary tract (NTS). The
NPG contains neurons that function as baroreceptors that sense blood pressure or as gustatory
afferents that transduce Na+-taste. Intriguingly, optogenetic excitation of afferents in the NTS arising
from NPGAT1aR significantly reduces blood pressure and Na+-intake. Moreover, mice overconsuming
NaCl solutions and rendered hypertensive via deliver of deoxycorticosterone acetate (DOCA-salt)
required greater frequencies of stimulation to lower blood pressure relative to normotensive mice.
Collectively, my preliminary results suggest that the NPGAT1aR send afferents to the NTS that mediate
the interoception of blood pressure and the perception of Na+-taste and the excitability of these neurons
can be used to study the etiology of hypertension that follows Na+ overconsumption. Accordingly, I
have developed the overall hypothesis that NPGAT1aR send afferents to the NTS that regulate blood
pressure and Na+-intake, and that AT1aR(s) on these neurons contribute to the development of DOCA-
salt hypertension. To confirm or refute this hypothesis, I will address the following aims. Aim 1 will use
neuroanatomical characterizations and optogenetic activation of NPGAT1aR afferents in the rostral and
caudal NTS to determine whether the connectivity and excitation of these afferents are sufficient to
alter Na+-intake and blood pressure under basal conditions and following depletion of blood volume.
Aim 2 will use Cre-LoxP system and virally-mediated gene transfer to selectively delete AT1aR(s) from
the NPG to determine whether these AT1aR are necessary for increased Na+-intake and decreased
baroreflex sensitivity that accompany the DOCA-salt model of hypertension. Collectively, these
experiments will shed light on gustatory and interoceptive integration in the brainstem to better
understand the relationship between Na+-intake and blood pressure regulation, thereby providing novel
insight that can be leveraged to develop treatments for hypertension.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Caitlin Marie Baum...的其他基金
Gustatory and interoceptive regulation of hypertension
高血压的味觉和内感受调节
- 批准号:1060895010608950
- 财政年份:2022
- 资助金额:$ 3.86万$ 3.86万
- 项目类别:
相似国自然基金
微囊泡介导肺泡上皮祖细胞醋酸盐代谢重编程向AT2细胞分化促进ARDS炎症修复的作用机制
- 批准号:82360020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
肝癌微环境富集醋酸盐增强内皮细胞乙酰化修饰并促进血管生成
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
肝癌微环境富集醋酸盐增强内皮细胞乙酰化修饰并促进血管生成
- 批准号:82273313
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
络合萃取法提取生物油酚类化合物的效能及机理研究
- 批准号:21206142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Evaluating the Mechanisms of Afferent Renal Nerve Ablation as a Treatment for Hypertension
评估传入肾神经消融治疗高血压的机制
- 批准号:1060470010604700
- 财政年份:2023
- 资助金额:$ 3.86万$ 3.86万
- 项目类别:
A new class of wet AMD therapeutics
新型湿性 AMD 疗法
- 批准号:1065958210659582
- 财政年份:2023
- 资助金额:$ 3.86万$ 3.86万
- 项目类别:
Investigating the role of CRAT as a driver of triple negative breast cancer chemoresistance
研究 CRAT 作为三阴性乳腺癌化疗耐药驱动因素的作用
- 批准号:1053607710536077
- 财政年份:2022
- 资助金额:$ 3.86万$ 3.86万
- 项目类别:
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
阐明肝脏 mTORC2 作为碳水化合物代谢关键调节因子在非酒精性脂肪肝中的作用
- 批准号:1054881610548816
- 财政年份:2022
- 资助金额:$ 3.86万$ 3.86万
- 项目类别:
Investigating the role of CRAT as a driver of triple negative breast cancer chemoresistance
研究 CRAT 作为三阴性乳腺癌化疗耐药驱动因素的作用
- 批准号:1067760910677609
- 财政年份:2022
- 资助金额:$ 3.86万$ 3.86万
- 项目类别: